- Presentations
- 3
- Markets
- 1
Gilotrif is a brand of Afatinib marketed by Boehringer Ingelheim Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Afatinib
- Brand owner
- Boehringer Ingelheim Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 20 mg tablet, 30 mg tablet, 40 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Gilotrif 20 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Gilotrif 30 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Gilotrif 40 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Gilotrif
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.